RDLCX
Price
$10.11
Change
+$0.05 (+0.50%)
Updated
Aug 28 closing price
Net Assets
295.81M
RGEBX
Price
$82.32
Change
+$0.51 (+0.62%)
Updated
Aug 28 closing price
Net Assets
327.53B
Interact to see
Advertisement

RDLCX vs RGEBX

Header iconRDLCX vs RGEBX Comparison
Open Charts RDLCX vs RGEBXBanner chart's image
Columbia Disciplined Growth C
Price$10.11
Change+$0.05 (+0.50%)
VolumeN/A
Net Assets295.81M
American Funds Growth Fund of Amer R2E
Price$82.32
Change+$0.51 (+0.62%)
VolumeN/A
Net Assets327.53B
RDLCX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RDLCX vs. RGEBX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDLCX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 328B vs. RDLCX (296M). RDLCX (0.00) and RGEBX (0.00) have matching dividends . RDLCX was incepted earlier than RGEBX: RDLCX (18 years) vs RGEBX (11 years). RDLCX (1.92) is less costly to investors than RGEBX (1.09). RDLCX is a more actively managed with annual turnover of: 68.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than RDLCX: RGEBX (250) vs RDLCX (2000). RGEBX annual gain was more profitable for investors over the last year : 14.97 vs. RDLCX (5.67). RGEBX return over 5 years is better than : 34.49 vs. RDLCX (-3.08).
RDLCXRGEBXRDLCX / RGEBX
Total Expense Ratio1.811.09166%
Annual Report Gross Expense Ratio1.921.09176%
Fund Existence18 years11 years-
Gain YTD9.22915.23061%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets296M328B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.6714.9738%
Returns for 3 years30.1452.2458%
Returns for 5 years-3.0834.49-9%
Returns for 10 years17.2591.3819%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLXN7.740.48
+6.54%
Silexion Therapeutics Corp
QUIK5.520.08
+1.47%
QuickLogic Corp
NBIX138.940.81
+0.59%
Neurocrine Biosciences
TRN28.61-0.18
-0.63%
Trinity Industries
BWMX13.32-0.11
-0.82%
Betterware de Mexico SAPI de CV